Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.

Saved in:
Bibliographic Details
Title: Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.
Authors: Gérard L; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France. laurence.gerard@sls.aphp.fr, Michot JM, Burcheri S, Fieschi C, Longuet P, Delcey V, Meignin V, Agbalika F, Chevret S, Oksenhendler E, Galicier L
Source: Blood [Blood] 2012 Mar 08; Vol. 119 (10), pp. 2228-33. Date of Electronic Publication: 2012 Jan 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood-2011-08-376012